Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason M Zimmerer

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2008
Critical role of effector macrophages in mediating CD4-dependent alloimmune injury of transplanted liver parenchymal cellsPhillip H Horne, Jason M Zimmerer, Mason G Fisher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Gene expression profiling reveals similarities between the in vitro and in vivo responses of immune effector cells to IFN-alphaJason M Zimmerer, Gregory B Lesinski, Amy S Ruppert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
IFN-alpha-2b-induced signal transduction and gene regulation in patient peripheral blood mononuclear cells is not enhanced by a dose increase from 5 to 10 megaunits/m2Jason M Zimmerer, Amy M Lehman, Amy S Ruppert, et al.
Transplantation Direct|January 13, 2025
Germinal Center B Cells are Uniquely Targeted by Antibody-Suppressor CXCR5<sup>+</sup>CD8<sup>+</sup> T CellsJason M Zimmerer, Sachi Chaudhari, Kavya Koneru, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2024
Antibody-Suppressor CXCR5+CD8+ T Cells Are More Potent Regulators of Humoral Alloimmunity after Kidney Transplant in Mice Compared to CD4+ Regulatory T CellsJing L Han, Jason M Zimmerer, Qiang Zeng, et al.
Transplantation|July 6, 2016
Unique CD8+ T Cell-Mediated Immune Responses Primed in the LiverJason M Zimmerer, Phillip H Horne, Mason G Fisher, et al.
Transplantation|October 24, 2023
CXCR5 + CD8 + T Cell-mediated Suppression of Humoral Alloimmunity and AMR in Mice Is Optimized With mTOR and Impaired With Calcineurin InhibitionJing L Han, Jason M Zimmerer, Qiang Zeng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2021
Invariant NKT Cells Promote the Development of Highly Cytotoxic Multipotent CXCR3<sup>+</sup>CCR4<sup>+</sup>CD8<sup>+</sup> T Cells That Mediate Rapid Hepatocyte Allograft RejectionJason M Zimmerer, Bryce A Ringwald, Sachi R Chaudhari, et al.
Cell Transplantation|October 17, 2012
Inhibition of recall responses through complementary therapies targeting CD8+ T-cell- and alloantibody-dependent allocytotoxicity in sensitized transplant recipientsJason M Zimmerer, Phillip H Horne, Lori A Fiessinger, et al.
Transplantation|February 8, 2020
Inverse Association Between the Quantity of Human Peripheral Blood CXCR5+IFN-γ+CD8+ T Cells With De Novo DSA Production in the First Year After Kidney TransplantJason M Zimmerer, Matthew W Basinger, Bryce A Ringwald, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2008
Critical role of effector macrophages in mediating CD4-dependent alloimmune injury of transplanted liver parenchymal cellsPhillip H Horne, Jason M Zimmerer, Mason G Fisher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Gene expression profiling reveals similarities between the in vitro and in vivo responses of immune effector cells to IFN-alphaJason M Zimmerer, Gregory B Lesinski, Amy S Ruppert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
IFN-alpha-2b-induced signal transduction and gene regulation in patient peripheral blood mononuclear cells is not enhanced by a dose increase from 5 to 10 megaunits/m2Jason M Zimmerer, Amy M Lehman, Amy S Ruppert, et al.
Transplantation Direct|January 13, 2025
Germinal Center B Cells are Uniquely Targeted by Antibody-Suppressor CXCR5<sup>+</sup>CD8<sup>+</sup> T CellsJason M Zimmerer, Sachi Chaudhari, Kavya Koneru, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2024
Antibody-Suppressor CXCR5+CD8+ T Cells Are More Potent Regulators of Humoral Alloimmunity after Kidney Transplant in Mice Compared to CD4+ Regulatory T CellsJing L Han, Jason M Zimmerer, Qiang Zeng, et al.
Transplantation|July 6, 2016
Unique CD8+ T Cell-Mediated Immune Responses Primed in the LiverJason M Zimmerer, Phillip H Horne, Mason G Fisher, et al.
Transplantation|October 24, 2023
CXCR5 + CD8 + T Cell-mediated Suppression of Humoral Alloimmunity and AMR in Mice Is Optimized With mTOR and Impaired With Calcineurin InhibitionJing L Han, Jason M Zimmerer, Qiang Zeng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2021
Invariant NKT Cells Promote the Development of Highly Cytotoxic Multipotent CXCR3<sup>+</sup>CCR4<sup>+</sup>CD8<sup>+</sup> T Cells That Mediate Rapid Hepatocyte Allograft RejectionJason M Zimmerer, Bryce A Ringwald, Sachi R Chaudhari, et al.
Cell Transplantation|October 17, 2012
Inhibition of recall responses through complementary therapies targeting CD8+ T-cell- and alloantibody-dependent allocytotoxicity in sensitized transplant recipientsJason M Zimmerer, Phillip H Horne, Lori A Fiessinger, et al.
Transplantation|February 8, 2020
Inverse Association Between the Quantity of Human Peripheral Blood CXCR5+IFN-γ+CD8+ T Cells With De Novo DSA Production in the First Year After Kidney TransplantJason M Zimmerer, Matthew W Basinger, Bryce A Ringwald, et al.
Pageof 3